Next, a total of 13 histologically validated human samples (Normal =3; NAFLD =10) were used to examine the expression levels of GTF2I and CHD2 (Fig. 6C). The gene discussed is CHD2; the disease is metabolic dysfunction-associated steatotic liver disease.